BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 8678780)

  • 1. Effects of nitric oxide donor SIN-1 on oxygen availability and regional blood flow during endotoxic shock.
    Zhang H; Rogiers P; Friedman G; Preiser JC; Spapen H; Buurman WA; Vincent JL
    Arch Surg; 1996 Jul; 131(7):767-74. PubMed ID: 8678780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of methylene blue on oxygen availability and regional blood flow during endotoxic shock.
    Zhang H; Rogiers P; Preiser JC; Spapen H; Manikis P; Metz G; Vincent JL
    Crit Care Med; 1995 Oct; 23(10):1711-21. PubMed ID: 7587237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of nitric oxide on blood flow distribution and O2 extraction capabilities during endotoxic shock.
    Zhang H; Rogiers P; Smail N; Cabral A; Preiser JC; Peny MO; Vincent JL
    J Appl Physiol (1985); 1997 Oct; 83(4):1164-73. PubMed ID: 9338425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal and hepatic perfusion and metabolism in hypodynamic endotoxic shock. Effects of nitric oxide synthase inhibition.
    Dahm PL; Thörne J; Myhre E; Grins E; Mårtensson L; Blomquist S
    Acta Anaesthesiol Scand; 1999 Jan; 43(1):56-63. PubMed ID: 9926190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of N-acetyl-L-cysteine on regional blood flow during endotoxic shock.
    Zhang H; Spapen H; Nguyen DN; Rogiers P; Bakker J; Vincent JL
    Eur Surg Res; 1995; 27(5):292-300. PubMed ID: 7589000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential hemodynamic effects of the nitric oxide donor pirsidomine in comparison to SIN-1, nitroprusside and nitroglycerin.
    Arkonac BM; Kersten JR; Wynsen JC; Nijhawan N; Warltier DC
    Pharmacology; 1996 Feb; 52(2):92-100. PubMed ID: 8851630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of a selective inhibitor of soluble guanylyl cyclase on global and regional hemodynamics during canine endotoxic shock.
    Preiser JC; Sun Q; Hadj-Sadok D; Vincent JL
    Shock; 2003 Nov; 20(5):465-8. PubMed ID: 14560112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of a nitric oxide donor and an inhibitor of nitric oxide synthase on blood flow and vascular resistance in feline submandibular, parotid and pancreatic glands.
    Lohinai Z; Balla I; Marczis J; Vass Z; Kovách AG
    Arch Oral Biol; 1996 Jul; 41(7):699-704. PubMed ID: 9015572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The platelet-activating factor antagonist BB-882 does not improve tissue oxygen extraction in endotoxic shock.
    Spapen H; Zhang H; Verhaeghe V; Smail N; Vincent JL
    J Crit Care; 1998 Jun; 13(2):81-90. PubMed ID: 9627275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of alpha - and beta -adrenergic stimulation on hepatosplanchnic perfusion and oxygen extraction in endotoxic shock.
    Zhang H; De Jongh R; De Backer D; Cherkaoui S; Vray B; Vincent JL
    Crit Care Med; 2001 Mar; 29(3):581-8. PubMed ID: 11373424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between selective and nonselective nitric oxide synthase inhibition and phenylephrine in normal and endotoxic swine.
    Cohen RI; Shapir Y; Davis A; Loona R; Scharf SM
    Crit Care Med; 2000 Sep; 28(9):3257-67. PubMed ID: 11008990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic and regional oxygen uptake and delivery and lactate flux in endotoxic dogs infused with dopexamine.
    Cain SM; Curtis SE
    Crit Care Med; 1991 Dec; 19(12):1552-60. PubMed ID: 1959377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NO donor SIN-1 improves intestinal-arterial P(CO(2)) gap in experimental endotoxemia: an animal study.
    Siegemund M; Van Bommel J; Sinaasappel M; Schwarte LA; Studer W; Girard T; Vollebregt K; Ince C
    Acta Anaesthesiol Scand; 2007 Jul; 51(6):693-700. PubMed ID: 17567269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrovascular effects of nitric oxide manipulation in spontaneously hypertensive rats.
    Fouyas IP; Kelly PA; Ritchie IM; Whittle IR
    Br J Pharmacol; 1997 May; 121(1):49-56. PubMed ID: 9146886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous venovenous hemofiltration improves cardiac performance by mechanisms other than tumor necrosis factor-alpha attenuation during endotoxic shock.
    Rogiers P; Zhang H; Smail N; Pauwels D; Vincent JL
    Crit Care Med; 1999 Sep; 27(9):1848-55. PubMed ID: 10507609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NG-monomethyl-l-arginine (NMA) restores arterial blood pressure but reduces cardiac output in a canine model of endotoxic shock.
    Klabunde RE; Ritger RC
    Biochem Biophys Res Commun; 1991 Aug; 178(3):1135-40. PubMed ID: 1872835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic response of endotoxemic calves to treatment with small-volume hypertonic saline solution.
    Constable PD; Schmall LM; Muir WW; Hoffsis GF; Shertel ER
    Am J Vet Res; 1991 Jul; 52(7):981-9. PubMed ID: 1892278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional effects of dobutamine in endotoxic shock.
    De Backer D; Zhang H; Manikis P; Vincent JL
    J Surg Res; 1996 Oct; 65(2):93-100. PubMed ID: 8903453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock.
    Robertson FM; Offner PJ; Ciceri DP; Becker WK; Pruitt BA
    Arch Surg; 1994 Feb; 129(2):149-55; discussion 155-6. PubMed ID: 7508219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of the veno-arterial response in the superior mesenteric artery during endotoxic shock.
    Revelly JP; Ayuse T; Brienza N; Robotham JL
    Crit Care Med; 1995 Sep; 23(9):1519-27. PubMed ID: 7664554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.